2Crowther CA,Harding J.Repeat doses of prenatal corticosteroids for women at risk of pretermbirth for preventing neonatal respiratory disease.Cochrane Database Syst Rev,2003,CD003935. 被引量：1
3Soll RF,Morley CJ.Prophylactic versus selective use of surfactant in preventing morbidity and mortality in preterm infants.Cochrane Database Syst Rev,2001,CD000510. 被引量：1
4Soll RF,Blanco F.Natural surfactant extract versus synthetic surfactant for neonatal respiratory distress syndrome.Cochrane Database Syst Rev,2001,CD000144. 被引量：1
5Ritchie J,Lewis J.Qualitative research practice:a guide for social science students and researchers.Thousand Oaks,New Delhi:Sage,2003.32-38. 被引量：1
6Garner P,Meremikwu M,Volmink J,et al.Putting evidence into practice:how middle and low income countries "get it together".BMJ,2004,329:1036-1039. 被引量：1
8Abalos E,Carroli G,Mackey ME.The tools and techniques of evidence-based medicine.Best Pract Res Clin Obstet Gynaecol,2005,19:15-26. 被引量：1
9Simpson KN,Lych SR.Cost savings from the use of antenatal steroids to prevent respiratory distress syndrome and relate conditions in premature infants.Am J Obstet Gynecol,1995,173:316-321. 被引量：1
